Skip to main content

Table 2 H. pylori eradication rates in the TBQT and LBQT groups

From: Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study

Eradication rate TBQT group (n = 182) LBQT group (n = 182) P value
ITT analysis 163/182 (89.6%) 118/182 (64.8%) < 0.001
PP analysis 163/179 (91.1%) 118/174 (67.8%) < 0.001
  1. TBQT tailored, bismuth-based quadruple therapy, amoxicillin + levofloxacin or furazolidone + esomeprazole + colloidal bismuth pectin, LBQT levofloxacin- and bismuth-based quadruple therapy. amoxicillin + levofloxacin + esomeprazole + colloidal bismuth pectin, ITT intention‐to‐treat, PP per protocol